Patents by Inventor Colin Powers

Colin Powers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
    Publication number: 20180147245
    Abstract: Compositions and methods for retargeting adenovirus to a cell using chemical dimers are described. In particular, a recombinant adenovirus comprising a nucleic acid comprising a capsid-dimerizing agent binder conjugate and a ligand-dimerizing agent binder conjugate is provided.
    Type: Application
    Filed: January 23, 2018
    Publication date: May 31, 2018
    Applicant: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Shigeki Miyake-Stoner, Colin Powers
  • ADENOVIRAL TUMOR DIAGNOSTICS
    Publication number: 20180100204
    Abstract: Compositions and methods for detecting a cancer in a subject using a recombinant reporter adenovirus are described. In particular, recombinant adenovirus is used to diagnose a cancer in a patient and further used for screening compounds effective in treating the cancer in said patient.
    Type: Application
    Filed: December 8, 2017
    Publication date: April 12, 2018
    Applicant: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Colin Powers
  • Selective cell targeting using adenovirus and chemical dimers
    Patent number: 9913866
    Abstract: Compositions and methods for retargeting adenovirus to a cell using chemical dimers are described. In particular, a recombinant adenovirus comprising a nucleic acid comprising a capsid-dimerizing agent binder conjugate and a ligand-dimerizing agent binder conjugate is provided.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: March 13, 2018
    Assignee: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Shigeki Miyake-Stoner, Colin Powers
  • Adenoviral tumor diagnostics
    Patent number: 9885090
    Abstract: Compositions and methods for detecting a cancer in a subject using a recombinant reporter adenovirus are described. In particular, recombinant adenovirus is used to diagnose a cancer in a patient and further used for screening compounds effective in treating the cancer in said patient.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: February 6, 2018
    Assignee: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Colin Powers
  • ADENOVIRAL ASSEMBLY METHOD
    Publication number: 20160053235
    Abstract: Methods of assembling modified adenoviruses, libraries of adenoviral gene modules and compositions thereof are provided herein.
    Type: Application
    Filed: November 9, 2015
    Publication date: February 25, 2016
    Applicant: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Colin Powers
  • Adenoviral assembly method
    Patent number: 9217160
    Abstract: Methods of assembling modified adenoviruses, libraries of adenoviral gene modules and compositions thereof are provided herein.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: December 22, 2015
    Assignee: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Colin Powers
  • Anti-cancer adenoviruses
    Patent number: 9187733
    Abstract: Anti-cancer adenoviruses, methods of use and methods of making the same are provided herein.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: November 17, 2015
    Assignee: Salk Institute for Biological Studies
    Inventors: Clodagh O'Shea, Colin Powers
  • SELECTIVE CELL TARGETING USING ADENOVIRUS AND CHEMICAL DIMERS
    Publication number: 20150017127
    Abstract: Compositions and methods for retargeting adenovirus to a cell using chemical dimers are described. In particular, a recombinant adenovirus comprising a nucleic acid comprising a capsid-dimerizing agent binder conjugate and a ligand-dimerizing agent binder conjugate is provided.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 15, 2015
    Inventors: Clodagh O'Shea, Shigeki Miyake-Stoner, Colin Powers
  • ADENOVIRAL TUMOR DIAGNOSTICS
    Publication number: 20150005397
    Abstract: Compositions and methods for detecting a cancer in a subject using a recombinant reporter adenovirus are described. In particular, recombinant adenovirus is used to diagnose a cancer in a patient and further used for screening compounds effective in treating the cancer in said patient.
    Type: Application
    Filed: September 12, 2014
    Publication date: January 1, 2015
    Inventors: Clodagh O'Shea, Colin Powers
  • ANTI-CANCER ADENOVIRUSES
    Publication number: 20130243729
    Abstract: Anti-cancer adenoviruses, methods of use and methods of making the same are provided herein.
    Type: Application
    Filed: February 15, 2013
    Publication date: September 19, 2013
    Applicant: SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: Clodagh O'Shea, Colin Powers
  • ADENOVIRAL ASSEMBLY METHOD
    Publication number: 20130231267
    Abstract: Methods of assembling modified adenoviruses, libraries of adenoviral gene modules and compositions thereof are provided herein.
    Type: Application
    Filed: February 15, 2013
    Publication date: September 5, 2013
    Applicant: SALK INSTITUTE FOR BIOLOGICAL STUDIES
    Inventors: Clodagh O'Shea, Colin Powers
  • RFID reader
    Patent number: D614628
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: April 27, 2010
    Assignee: Cathexis Innovations, Inc.
    Inventors: Steven Taylor, Colin Power, Stephan Gagnon